Levitate Bio
Cambridge, United States· Est.
Focuses on developing RNA-based therapeutics using novel delivery platforms for genetic diseases.
Private Company
Total funding raised: $4.2M
About
Focuses on developing RNA-based therapeutics using novel delivery platforms for genetic diseases.
RNA TherapeuticsGene Therapy
Funding History
1Total raised:$4.2M
Seed$4.2M